Curable resin composition and display device
The curable resin composition, with quantum dots and specifically formulated resin and photopolymerizable compounds, addresses the challenge of prolonged development times in thick films, achieving fast development and high luminescence intensity.
Patent Information
- Application Number
- KR1020227025711
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-12-26
- Filing Date
- 2020-12-23
- Publication Date
- 2026-11-11
- Estimated Expiration
- 2040-12-23
AI Technical Summary
Existing curable resin compositions face prolonged development times when forming thick films to increase luminescence intensity, leading to inefficiencies in manufacturing processes.
A curable resin composition comprising quantum dots, a resin with specific molecular weight and acid value, photopolymerizable compounds, photopolymerization initiators, antioxidants, leveling agents, and solvents, optimized to achieve fast development times and high luminescence intensity even in thick films.
The composition enables rapid film development and maintains high luminescence intensity, improving manufacturing efficiency and film quality.
Smart Images

Figure 112022077041827-PCT00001 
Figure 112022077041827-PCT00002 
Figure 112022077041827-PCT00003
Abstract
Description
Technology Field
[0001] The present invention relates to a curable resin composition, and also to a cured film and a display device including the same. Background Technology
[0002] Patent Document 1 describes a curable resin composition containing quantum dots. Prior art literature
[0003] Japanese Patent Publication No. 2016-065178 The problem to be solved
[0004] When forming a cured film using the curable resin composition described in Patent Document 1, if the thickness of the coating film of the curable resin composition is increased in order to increase the luminescence intensity, the development time may be prolonged.
[0005] The objective of the present invention is to provide a curable resin composition that enables a film with a fast development time and high luminescence intensity, even when the film is thick. means of solving the problem
[0006] The present invention provides the following curable resin composition, curable film, display device, and method for manufacturing a curable resin composition.
[0007] [1] Includes quantum dots (A), resin (B), photopolymerizable compound (C), photopolymerization initiator (D), antioxidant (E), leveling agent (F) and solvent (G),
[0008] The above resin (B) is a curable resin composition having a weight-average molecular weight in polystyrene equivalent of less than 10,000 and an acid value of 90 mgKOH / g or more and 150 mgKOH / g or less.
[0009] [2] The above resin (B) is a curable resin composition described in [1], comprising a resin having an acrylic equivalent of 300 g / eq or more and 2,000 g / eq or less.
[0010] [3] A curable resin composition as described in [1] or [2], wherein the mass ratio of the resin (B) to the photopolymerizable compound (C) is 1 or more.
[0011] [4] The above photopolymerization initiator (D) is a curable resin composition described in any one of [1] to [3], comprising an oxime compound.
[0012] [5] The above antioxidant (E) is a curable resin composition described in any one of [1] to [4], comprising a phosphorus / phenol complex type antioxidant.
[0013] [6] The leveling agent (F) is a curable resin composition described in any one of [1] to [5], comprising a fluorine-based surfactant or a silicone-based surfactant.
[0014] [7] A curable resin composition described in any one of [1] to [6] that does not contain either an aliphatic tertiary amine compound or an aliphatic quaternary ammonium salt compound, or contains at least one of an aliphatic tertiary amine compound and an aliphatic quaternary ammonium salt compound in an amount of less than 0.4 mass% relative to the total amount of solids of the curable resin composition.
[0015] [8] A cured film formed from a curable resin composition described in any of [1] to [7].
[0016] [9] A display device including a hardened film as described in [8].
[0017]
[10] As a method for manufacturing a curable resin composition as described in [1],
[0018] The process includes preparing the above resin (B),
[0019] A method for manufacturing the above resin (B), wherein the above resin (B) does not contain either an aliphatic tertiary amine compound or an aliphatic quaternary ammonium salt compound, or contains at least one of an aliphatic tertiary amine compound and an aliphatic quaternary ammonium salt compound in an amount of less than 0.8 mass% relative to the total amount of solids of the above resin (B).
[0020]
[11] A manufacturing method described in
[10] that does not use an amine compound as a reaction catalyst in the process of preparing the above resin (B). Effects of the invention
[0021] According to the present invention, a curable resin composition can be provided that allows for a fast development time and a high luminescence intensity to be obtained even if the film is thick. Specific details for implementing the invention
[0022] Curable Resin Composition
[0023] The curable resin composition related to the present invention comprises a quantum dot (A), a resin (B), a photopolymerizable compound (C), a photopolymerization initiator (D), an antioxidant (E), a leveling agent (F), and a solvent (G).
[0024] [1] Quantum Dot (A)
[0025] Quantum dots (A) are semiconductor particles with a particle diameter of 1 nm or more and 100 nm or less, and are particles that utilize the band gap of the semiconductor and emit light by absorbing ultraviolet light or visible light.
[0026] As quantum dots (A), compounds of group 12 elements such as CdS, CdSe, CdTe, ZnS, ZnSe, ZnTe, HgS, HgSe, HgTe, CdHgTe, CdSeS, CdSeTe, CdSTe, ZnSeS, ZnSeTe, ZnSTe, HgSeS, HgSeTe, HgSTe, CdZnS, CdZnSe, CdZnTe, CdHgS, CdHgSe, CdHgTe, HgZnS, HgZnSe, HgZnTe, CdZnSeS, CdZnSeTe, CdZnSTe, CdHgSeS, CdHgSeTe, CdHgSTe, HgZnSeS, HgZnSeTe, HgZnSTe, etc. and group 16 elements; Examples include compounds of Group 13 elements and Group 15 elements such as GaN, GaP, GaAs, AlN, AlP, AlAs, InN, InP, InAs, GaNP, GaNAs, GaPAs, AlNP, AlNAs, AlPAs, InNP, InNAs, InPAs, GaAlNP, GaAlNAs, GaAlPAs, GaInNP, GaInNAs, GaInPAs, InAlNP, InAlNAs, InAlPAs; compounds of Group 14 elements and Group 16 elements such as PdS, PbSe, etc.
[0027] When the quantum dot (A) contains S or Se, a quantum dot surface modified with a metal oxide or an organic material may be used. By using a surface modified quantum dot, it is possible to prevent S or Se from being drawn out by the reactive components in the material forming the organic layer.
[0028] Additionally, the quantum dot (A) may form a core-cell structure by combining the above compounds. Examples of such combinations include microparticles in which the core is CdSe and the cell is ZnS.
[0029] Since the energy state of the quantum dot (A) depends on its size, it is possible to freely select the emission wavelength by changing the particle size. For example, in the case of a quantum dot composed solely of CdSe, the peak wavelengths of the fluorescence spectrum when the particle size is 2.3 nm, 3.0 nm, 3.8 nm, and 4.6 nm are 528 nm, 570 nm, 592 nm, and 637 nm, respectively. In addition, the light emitted from the quantum dot (A) has a narrow spectral width, and by combining light having such steep peaks, the displayable color gamut of the display device is expanded. Furthermore, the quantum dot (A) has high responsiveness and can efficiently utilize the light emitted from the light source.
[0030] The curable resin composition of the present invention may contain only quantum dots that emit light of a specific wavelength when radiated from a light source, or may contain a combination of two or more types of quantum dots that emit light of different wavelengths. Examples of the light of the specific wavelength include red light, green light, and blue light.
[0031] The content of the quantum dot (A) may be, for example, 0.1 mass% or more and 60 mass% or less with respect to the total amount of solids of the curable resin composition, preferably 5 mass% or more and 50 mass% or less, and more preferably 20 mass% or more and 45 mass% or less. In this specification, the total amount of solids refers to the sum of the components of the curable resin composition excluding the solvent (G) described below. The content of the solids of the curable resin composition can be measured by known analytical means such as liquid chromatography or gas chromatography.
[0032] [2] Suji (B)
[0033] The resin (B) has a weight-average molecular weight in terms of polystyrene equivalent of less than 10,000, and may, for example, be 9,000 or less. By having the above weight-average molecular weight in terms of polystyrene equivalent, the development speed is fast even for thick films, and there is a tendency to obtain films with high luminescence intensity. The weight-average molecular weight in terms of polystyrene equivalent of the resin (B) may, for example, be in the range of 1,000 or more and 9,000 or less, and from the perspective of development speed and luminescence intensity, it is preferably in the range of 2,000 or more and 8,500 or less, more preferably 3,000 or more and 8,500 or less. The weight-average molecular weight in terms of polystyrene equivalent of the resin (B) is measured according to the measurement method in the section of the examples described below. By having the above weight-average molecular weight in terms of polystyrene equivalent of the resin (B), there is a tendency to obtain films in which the amount of outgassing released by heating is reduced. As the resin (B) has a weight-average molecular weight equivalent to polystyrene within the above range, it tends to be easier to obtain a film that exhibits excellent solvent resistance.
[0034] The acid value of the resin (B) is in the range of 90 mgKOH / g or more and 150 mgKOH / g or less based on the solid content. If the acid value is less than 90 mgKOH / g, solubility in the alkaline developer is reduced, which may leave residue on the substrate, and if the acid value exceeds 150 mgKOH / g, the likelihood of pattern peeling increases. From the perspective of developability, the acid value of the resin (B) is preferably in the range of 95 mgKOH / g or more and 140 mgKOH / g or less, and more preferably in the range of 100 mgKOH / g or more and 130 mgKOH / g or less. Here, the acid value is a value measured as the amount (mg) of potassium hydroxide required to neutralize 1 g of resin (D), and can be obtained, for example, by titrating using an aqueous potassium hydroxide solution. The acid value of the resin (B) is measured according to the measurement method in the section of the examples described below. As the resin (B) has an acid value within the above range, it tends to be easier to obtain a film that exhibits excellent solvent resistance.
[0035] The molecular weight distribution [weight-average molecular weight (Mw) / number-average molecular weight (Mn)] of the resin (B) may be, for example, 1.0 or more and 6.0 or less, and preferably 1.2 or more and 4.0 or less from the perspective of formability.
[0036] As for resins (B), the following resins [K1] to [K4] can be cited.
[0037] Resin [K1]; a copolymer of at least one type (a) selected from the group consisting of unsaturated carboxylic acids and unsaturated carboxylic acid anhydrides (hereinafter referred to as “(a)”) and a monomer (c) copolymerizable with (a) (provided that it is different from (a)) (hereinafter referred to as “(c)”);
[0038] Resin [K2]; a resin formed by reacting a monomer (b) having a cyclic ether structure having 2 to 4 carbon atoms and an ethylenically unsaturated bond (hereinafter referred to as “(b)”) with the copolymer of (a) and (c);
[0039] Resin [K3]; resin obtained by reacting (a) with the copolymer of (b) and (c);
[0040] Resin [K4]; a resin in which (a) is reacted with a copolymer of (b) and (c), and further reacted with a carboxylic acid anhydride.
[0041] (a) specifically, for example, unsaturated monocarboxylic acids such as (meth)acrylic acid, crotonic acid, o-, m-, p-vinyl benzoic acid;
[0042] Unsaturated dicarboxylic acids such as maleic acid, fumaric acid, citraconic acid, mesaconic acid, itaconic acid, 3-vinylphthalic acid, 4-vinylphthalic acid, 3,4,5,6-tetrahydrophthalic acid, 1,2,3,6-tetrahydrophthalic acid, dimethyltetrahydrophthalic acid, and 1,4-cyclohexenedicarboxylic acid;
[0043] Bicyclounsaturated compounds containing a carboxyl group, such as methyl-5-norbornene-2,3-dicarboxylic acid, 5-carboxybicyclo[2.2.1]hept-2-en, 5,6-dicarboxybicyclo[2.2.1]hept-2-en, 5-carboxy-5-methylbicyclo[2.2.1]hept-2-en, 5-carboxy-5-ethylbicyclo[2.2.1]hept-2-en, 5-carboxy-6-methylbicyclo[2.2.1]hept-2-en, and 5-carboxy-6-ethylbicyclo[2.2.1]hept-2-en;
[0044] Unsaturated dicarboxylic acid anhydrides such as maleic anhydride, citraconic anhydride, itaconic anhydride, 3-vinylphthalic anhydride, 4-vinylphthalic anhydride, 3,4,5,6-tetrahydrophthalic anhydride, 1,2,3,6-tetrahydrophthalic anhydride, dimethyltetrahydrophthalic anhydride, 5,6-dicarboxybicyclo[2.2.1]hept-2-ene anhydride;
[0045] Unsaturated mono[(meth)acryloyloxyalkyl] esters of divalent or higher polycarboxylic acids such as succinate mono[2-(meth)acryloyloxyethyl] and phthalate mono[2-(meth)acryloyloxyethyl];
[0046] Examples include unsaturated acrylates containing hydroxyl and carboxyl groups within the same molecule, such as α-(hydroxymethyl)acrylic acid.
[0047] Among these, (meth)acrylic acid, maleic anhydride, etc. are preferred in terms of copolymerization reactivity and the solubility of the resulting resin in an alkaline aqueous solution.
[0048] Herein, (meth)acrylic acid means acrylic acid and / or methacrylic acid. The same applies hereinafter to "(meth)acryloyl," "(meth)acrylate," etc.
[0049] (b) is, for example, a monomer having a cyclic ether structure having 2 to 4 carbon atoms (for example, at least one selected from the group consisting of an oxiran ring, an oxetane ring, and a tetrahydrofuran ring) and an ethylenically unsaturated bond. (b) is preferably a monomer having a cyclic ether structure having 2 to 4 carbon atoms and a (meth)acryloyloxy group.
[0050] (b) Glycidyl(meth)acrylate, β-methylglycidyl(meth)acrylate, β-ethylglycidyl(meth)acrylate, glycidyl vinyl ether, o-vinylbenzylglycidyl ether, m-vinylbenzylglycidyl ether, p-vinylbenzylglycidyl ether, α-methyl-o-vinylbenzylglycidyl ether, α-methyl-m-vinylbenzylglycidyl ether, α-methyl-p-vinylbenzylglycidyl ether, 2,3-bis(glycidyloxymethyl)styrene, 2,4-bis(glycidyloxymethyl)styrene, 2,5-bis(glycidyloxymethyl)styrene, 2,6-bis(glycidyloxymethyl)styrene, 2,3,4-tris(glycidyloxymethyl)styrene, A monomer having an oxyran ring and an ethylenically unsaturated bond, such as 2,3,5-tris(glycidyloxymethyl)styrene, 2,3,6-tris(glycidyloxymethyl)styrene, 3,4,5-tris(glycidyloxymethyl)styrene, and 2,4,6-tris(glycidyloxymethyl)styrene; Examples include monomers having an ethylene unsaturated bond with an oxetane ring, such as 3-methyl-3-methacryloyloxymethyloxetane, 3-methyl-3-acryloyloxymethyloxetane, 3-ethyl-3-methacryloyloxymethyloxetane, 3-ethyl-3-acryloyloxymethyloxetane, 3-methyl-3-acryloyloxyethyloxetane, 3-ethyl-3-methacryloyloxyethyloxetane, 3-ethyl-3-methacryloyloxyethyloxetane, 3-ethyl-3-acryloyloxyethyloxetane; monomers having an ethylene unsaturated bond with a tetrahydrofuran ring, such as tetrahydrofurfuryl acrylate (e.g., Viscot V#150, manufactured by Osaka Organic Chemical Industry Co., Ltd.), and tetrahydrofurfuryl methacrylate.
[0051] Since the reactivity is high during the production of resins [K2] to [K4] and unreacted (b) is unlikely to remain, a monomer having an oxyran ring and an ethylenically unsaturated bond is preferred as (b).
[0052] (c) includes, for example, methyl(meth)acrylate, ethyl(meth)acrylate, n-butyl(meth)acrylate, sec-butyl(meth)acrylate, tert-butyl(meth)acrylate, 2-ethylhexyl(meth)acrylate, dodecyl(meth)acrylate, lauryl(meth)acrylate, stearyl(meth)acrylate, cyclopentyl(meth)acrylate, cyclohexyl(meth)acrylate, 2-methylcyclohexyl(meth)acrylate, tricyclo[5.2.1.0 2,6 ] Decane-8-yl (meth)acrylate (in the art, it is commonly referred to as "dicyclofentanyl (meth)acrylate." It is also sometimes referred to as "tricyclodecyl (meth)acrylate."), tricyclo[5.2.1.0 2,6 ](Metha)acrylate (known by the common name "Dicyclofentenyl(Metha)acrylate" in the relevant technical field), (Metha)acrylic acid esters such as dicyclofentanyloxyethyl(Metha)acrylate, isobornyl(Metha)acrylate, adamantyl(Metha)acrylate, allyl(Metha)acrylate, propargyl(Metha)acrylate, phenyl(Metha)acrylate, naphthyl(Metha)acrylate, and benzyl(Metha)acrylate;
[0053] Hydroxy group-containing (meth)acrylic acid esters such as 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, etc.;
[0054] Dicarboxylic acid diesters such as diethyl maleate, diethyl fumarate, and diethyl itaconate;
[0055] Bicyclo[2.2.1]hept-2-en, 5-methylbicyclo[2.2.1]hept-2-en, 5-ethylbicyclo[2.2.1]hept-2-en, 5-hydroxybicyclo[2.2.1]hept-2-en, 5-hydroxymethylbicyclo[2.2.1]hept-2-en, 5-(2'-hydroxyethyl)bicyclo[2.2.1]hept-2-en, 5-methoxybicyclo[2.2.1]hept-2-en, 5-ethoxybicyclo[2.2.1]hept-2-en, 5,6-dihydroxybicyclo[2.2.1]hept-2-en, 5,6-di(hydroxymethyl)bicyclo[2.2.1]hept-2-en, 5,6-di(2'-hydroxyethyl)bicyclo[2.2.1]hept-2-en, 5,6-dimethoxybicyclo[2.2.1]hept-2-en, 5,6-diethoxybicyclo[2.2.1]hept-2-en, 5-hydroxy-5-methylbicyclo[2.2.1]hept-2-en, 5-hydroxy-5-ethylbicyclo[2.2.1]hept-2-en, 5-hydroxymethyl-5-methylbicyclo[2.2.1]hept-2-en, 5-tert-butoxycarbonylbicyclo[2.2.1]hept-2-en, 5-cyclohexyloxycarbonylbicyclo[2.2.1]hept-2-en, Bicyclounsaturated compounds such as 5-phenoxycarbonylbicyclo[2.2.1]hept-2-en, 5,6-bis(tert-butoxycarbonyl)bicyclo[2.2.1]hept-2-en, 5,6-bis(cyclohexyloxycarbonyl)bicyclo[2.2.1]hept-2-en;
[0056] Dicarbonylimide derivatives such as N-phenylmaleimide, N-cyclohexylmaleimide, N-benzylmaleimide, N-succinimidyl-3-maleimidebenzoate, N-succinimidyl-4-maleimidebutyrate, N-succinimidyl-6-maleimidecaproate, N-succinimidyl-3-maleimidepropionate, N-(9-acridinyl)maleimide;
[0057] Examples include styrene, α-methylstyrene, m-methylstyrene, p-methylstyrene, vinyltoluene, p-methoxystyrene, acrylonitrile, methacrylonitrile, vinyl chloride, vinylidene chloride, acrylamide, methacrylamide, vinyl acetate, 1,3-butadiene-isoprene, 2,3-dimethyl-1,3-butadiene, etc.
[0058] Among these, styrene, vinyltoluene, N-phenylmaleimide, N-cyclohexylmaleimide, N-benzylmaleimide, bicyclo[2.2.1]hept-2-ene, etc. are preferred in terms of copolymerization reactivity and heat resistance.
[0059] In resin [K1], the proportion of structural units derived from each is, among the total structural units constituting resin [K1],
[0060] Structural unit derived from (a); 2 mol% or more and 60 mol% or less
[0061] Structural unit derived from (c); 40 mol% or more and 98 mol% or less
[0062] It is desirable that,
[0063] Structural unit derived from (a); 10 mol% or more and 50 mol% or less
[0064] Structural unit derived from (c); 50 mol% or more and 90 mol% or less
[0065] It is more desirable to be.
[0066] When the ratio of the structural unit of the resin [K1] is within the above range, the storage stability of the curable composition, the developability when forming a curing pattern, and the solvent resistance of the obtained curing pattern tend to be excellent.
[0067] Resin [K1] can be manufactured by referring to the method described in the document “Experimental Methods for Polymer Synthesis” (authored by Takayuki Otsu, published by Chemical Doujin Co., Ltd., 1st edition, 1st printing, March 1, 1972) and the cited literature mentioned in the said document.
[0068] Specifically, a method may be used in which a predetermined amount of (a) and (c), a polymerization initiator, and a solvent are placed into a reaction vessel, and a deoxygenated atmosphere is created by, for example, replacing oxygen with nitrogen, and the mixture is heated and maintained while stirring. Furthermore, the polymerization initiator and solvent used herein are not particularly limited and may be those commonly used in the field. For example, as a polymerization initiator, an azo compound (2,2'-azobis(isobutyronitrile, 2,2'-azobis(2,4-dimethylvaleronitrile), etc.) or an organic peroxide (benzoyl peroxide, etc.) may be used, and as a solvent, any solvent that dissolves each monomer may be used, and the solvent described below may be used as a solvent (G) that may be included in the curable composition of the present invention.
[0069] In addition, the obtained copolymer may be used as is after the reaction solution, as a concentrated or diluted solution, or as a solid (powder) extracted by methods such as reprecipitation. In particular, by using the solvent (G) described below as the solvent during this polymerization, the solution after the reaction can be used as is for preparing the curable composition of the present invention, thereby simplifying the manufacturing process of the curable composition of the present invention.
[0070] The resin [K2] can be prepared by obtaining a copolymer of (a) and (c) and adding a cyclic ether having 2 to 4 carbon atoms of (b) to a carboxylic acid and / or carboxylic anhydride of (a).
[0071] First, the copolymers of (a) and (c) are prepared in the same manner as described for the method of preparing resin [K1]. In this case, it is preferable that the ratio of structural units derived from each be the same as that of resin [K1].
[0072] Next, a cyclic ether having 2 to 4 carbon atoms of (b) is reacted with a portion of the carboxylic acid and / or carboxylic anhydride derived from (a) in the copolymer.
[0073] After preparing the copolymer of (a) and (c), the atmosphere inside the flask is replaced from nitrogen to air, and (b) a reaction catalyst (e.g., an organic phosphorus compound, a metal complex, an amine compound, etc.) and a polymerization inhibitor (e.g., hydroquinone, etc.) are reacted for 1 to 10 hours at, for example, between 60°C and 130°C. A resin [K2] can be prepared.
[0074] The amount of (b) used is preferably 5 moles or more and 80 moles or less, and more preferably 10 moles or more and 75 moles or less, with respect to 100 moles of (a). By keeping it within this range, the balance of storage stability of the curable composition, developability when forming a curing pattern, and solvent resistance, heat resistance, mechanical strength, and sensitivity of the obtained curing pattern tends to be good.
[0075] Examples of organic phosphorus compounds used as reaction catalysts include triphenylphosphine. Examples of amine compounds used as reaction catalysts include aliphatic tertiary amine compounds and aliphatic quaternary ammonium salt compounds, and specific examples include tris(dimethylaminomethyl)phenol, triethylamine, tetrabutylammonium bromide, tetrabutylammonium chloride, etc. Preferably, they are organic phosphorus compounds in terms of developability and luminescence intensity.
[0076] The amount of the above reaction catalyst used is preferably 0.001 parts by mass or more and 5 parts by mass or less with respect to 100 parts by mass of the total amount of (a), (b), and (c). The amount of the above polymerization inhibitor used is preferably 0.001 parts by mass or more and 5 parts by mass or less with respect to 100 parts by mass of the total amount of (a), (b), and (c).
[0077] Reaction conditions, such as the introduction method, reaction temperature, and time, can be appropriately adjusted by considering the manufacturing equipment or the heat generated by polymerization. In addition, similar to polymerization conditions, the introduction method or reaction temperature can be appropriately adjusted by considering the manufacturing equipment or the heat generated by polymerization.
[0078] As a first step, the copolymer of (b) and (c) is obtained by the same method as the resin [K1] described above. As above, the obtained copolymer may be used as is after the reaction solution, or a concentrated or diluted solution may be used, or a solid (powder) extracted by means such as reprecipitation may be used.
[0079] The proportion of structural units derived from (b) and (c) is, respectively, with respect to the total moles of all structural units constituting the copolymer,
[0080] Structural unit derived from (b); 5 mol% or more and 95 mol% or less
[0081] Structural unit derived from (c); 5 mol% or more and 95 mol% or less
[0082] It is desirable that,
[0083] Structural unit derived from (b); 10 mol% or more and 90 mol% or less
[0084] Structural unit derived from (c); 10 mol% or more and 90 mol% or less
[0085] It is more desirable to be.
[0086] In addition, resin [K3] can be obtained by reacting the cyclic ether derived from (b) of the copolymer of (b) and (c) with the carboxylic acid or carboxylic anhydride of (a) under conditions similar to the method of manufacturing resin [K2].
[0087] The amount of (a) used to react with the copolymer is preferably 5 moles or more and 80 moles or less per 100 moles of (b).
[0088] Resin [K4] is a resin in which a carboxylic anhydride is additionally reacted with resin [K3]. A carboxylic anhydride is reacted with the hydroxyl group generated by the reaction of a cyclic ether with a carboxylic acid or a carboxylic anhydride.
[0089] Examples of carboxylic acid anhydrides include maleic anhydride, citraconic acid anhydride, itaconic acid anhydride, 3-vinylphthalic anhydride, 4-vinylphthalic anhydride, 3,4,5,6-tetrahydrophthalic anhydride, 1,2,3,6-tetrahydrophthalic anhydride, dimethyltetrahydrophthalic anhydride, 5,6-dicarboxybicyclo[2.2.1]hept-2-ene anhydride, etc. The amount of carboxylic acid anhydride used is preferably 0.5 to 1 mole per 1 mole of the amount used in (a).
[0090] As resins [K1], [K2], [K3] and [K4], specifically, resin [K1] is a benzyl (meth)acrylate / (meth)acrylic acid copolymer, styrene / (meth)acrylic acid copolymer, etc.; resin [K2] is a resin obtained by adding glycidyl (meth)acrylate to a benzyl (meth)acrylate / (meth)acrylic acid copolymer, a resin obtained by adding glycidyl (meth)acrylate to a tricyclodecyl (meth)acrylate / styrene / (meth)acrylic acid copolymer, a resin obtained by adding glycidyl (meth)acrylate to a tricyclodecyl (meth)acrylate / benzyl (meth)acrylate / (meth)acrylic acid copolymer, etc.; Examples include resins such as a resin formed by reacting (meth)acrylic acid with a copolymer of tricyclodecyl (meth)acrylate / glycidyl (meth)acrylate, a resin formed by reacting (meth)acrylic acid with a copolymer of tricyclodecyl (meth)acrylate / styrene / glycidyl (meth)acrylate [K3]; and resins such as a resin formed by reacting (meth)acrylic acid with a copolymer of tricyclodecyl (meth)acrylate / glycidyl (meth)acrylate and additionally reacting tetrahydrophthalic anhydride [K4].
[0091] Among them, as for the resin (B), it is preferable to include at least one selected from the group consisting of resin [K2], resin [K3] and resin [K4].
[0092] As an additional example of resin (B), an alkali-soluble resin described in Japanese Patent Publication No. 2018-123274 may be cited. Specifically, a polymer (hereinafter also referred to as resin (Ba)) may be cited, which has double bonds in the side chains and, in the main chain, includes a constituent unit (α) represented by the following general formula (I) and a constituent unit (β) represented by the following general formula (II), and additionally includes an acid group. The acid group may be introduced into the resin, for example, by the resin (Ba) including a constituent unit (γ) derived from an acid group-containing monomer (e.g., (meth)acrylic acid, etc.). Preferably, the resin (Ba) includes constituent units (α), (β), and (γ) in the main chain backbone.
[0093] [Chemical Formula 1]
[0094]
[0095] [In the formula, R 1 and R 2 represents a hydrogen atom or a hydrocarbon group having 1 to 25 carbon atoms, identical or different. n represents the average number of repeating units of the constituent unit represented by general formula (I), and is a number greater than or equal to 1.
[0096] [Chemical Formula 2]
[0097]
[0098] [In the formula, R 3 Silver, identical or different, represents a hydrogen atom or a methyl group. R 4 represents a straight or branched hydrocarbon group having 4 to 20 carbon atoms, identical or different. m represents the average number of repeating units of the constituent unit represented by general formula (II), and is a number greater than or equal to 1.
[0099] In the resin (Ba), the content ratio of the constituent unit (α) may be 0.5 mass% or more and 50 mass% or less with respect to the total amount of all monomer units that provide the main chain backbone of the resin (Ba) at 100 mass%, for example, from the perspective of heat resistance or storage stability, preferably 1 mass% or more and 40 mass% or less, and more preferably 5 mass% or more and 30 mass% or less. n in the general formula (I) represents the average number of repeating units of the constituent unit (α) in the resin (Ba), and n can be set so that the content ratio of the constituent unit (α) is within the above range.
[0100] The content ratio of the constituent unit (β) may be, for example, 10 mass% or more and 90 mass% or less with respect to 100 mass% of the total amount of monomer units that provide the main chain backbone of the resin (Ba) from the perspective of solvent resistance, preferably 20 mass% or more and 80 mass% or less, and more preferably 30 mass% or more and 75 mass% or less. m in general formula (II) represents the average number of repeating units of the constituent unit (β) in the resin (Ba), and m can be set so that the content ratio of the constituent unit (β) is within the range described above.
[0101] The content ratio of the constituent unit (γ) may be, for example, 0.5 mass% or more and 50 mass% or less with respect to solubility in alkaline substances or solubility in solvents, with respect to the total amount of monomer units that provide the main chain skeleton of the resin (Ba) at 100 mass%, preferably 2 mass% or more and 50 mass% or less, more preferably 5 mass% or more and 45 mass% or less.
[0102] The resin (B) may include one or more selected from the group consisting of the resin [K1], resin [K2], resin [K3], resin [K4] and resin (Ba) described above.
[0103] In order to make the weight-average molecular weight of the resin (B) 9000 or less, reaction conditions such as the selection of raw materials used, the method of introduction, and the reaction temperature and time can be appropriately combined and adjusted.
[0104] The resin (B) may include a resin having an acrylic equivalent of, for example, 300 g / eq or more and 2000 g / eq or less (hereinafter also referred to as an acrylic resin). The acrylic resin preferably has an acrylic equivalent of 500 g / eq or more and 1500 g / eq or less. When the resin (B) includes an acrylic resin, it tends to be easier to prevent the phenomenon of light extinction during the color filter process. On the other hand, when the resin (B) includes a resin with an acrylic equivalent exceeding 2000 g / eq, it tends to be difficult to obtain the ability to effectively protect the quantum dots, and when the resin includes a resin with an acrylic equivalent below the above range, it tends to be easy to peel off without dissolving during development. Preferably, the resin (B) is an acrylic resin. By having an acrylic equivalent within the above range, it tends to be easier to obtain a film in which the amount of outgassing released by heating is reduced. As the resin (B) has an acrylic equivalent within the above range, it tends to be easier to obtain a film that exhibits excellent solvent resistance.
[0105] The content of resin (B) in the curable resin composition may be, for example, 5 mass% or more and 80 mass% or less with respect to the total amount of solids of the curable resin composition, preferably 10 mass% or more and 70 mass% or less, more preferably 13 mass% or more and 60 mass% or less, and even more preferably 17 mass% or more and 55 mass% or less. When the content of resin (B) is within the above range, quantum dots tend to be easily dispersed, and there is also a tendency to maintain high luminescence efficiency during the process.
[0106] In terms of developability and luminescence intensity, the resin (B) preferably does not contain either an aliphatic tertiary amine compound or an aliphatic quaternary ammonium salt compound, or contains at least one of the aliphatic tertiary amine compound or an aliphatic quaternary ammonium salt compound in an amount of less than 0.4 mass% relative to the total amount of solids of the curable resin composition. In addition, in terms of developability and luminescence intensity, the curable resin composition preferably does not contain either an aliphatic tertiary amine compound or an aliphatic quaternary ammonium salt compound, or contains at least one of the aliphatic tertiary amine compound or an aliphatic quaternary ammonium salt compound in an amount of less than 0.4 mass% relative to the total amount of solids of the curable resin composition. In the manufacturing process of the resin (B), in terms of developability and luminescence intensity, an amine compound is preferably not used as a reaction catalyst. The content of the aliphatic tertiary amine compound and the aliphatic quaternary ammonium salt compound can be measured according to the measurement method in the section of the examples described below. In a curable resin composition, the content of an aliphatic tertiary amine compound and an aliphatic quaternary ammonium salt compound may be, for example, less than 0.4 mass% with respect to the total amount of solids of the curable resin composition.
[0107] In a curable resin composition, the mass ratio (solid ratio) of the resin (B) to the photopolymerizable compound (C) described below may be, for example, 1 or more, preferably 1.5 or more, more preferably 2 or more, and even more preferably 2.5 or more from the perspective of developability and luminescence intensity.
[0108] [3] Photopolymerizable compound (C)
[0109] The photopolymerizable compound (C) is a compound that can be polymerized by an active radical, acid, etc. generated from the photopolymerization initiator (D) described later, and examples include compounds having ethylenically unsaturated bonds, and preferably (meth)acrylic acid ester compounds.
[0110] In addition, in this specification, "(meth)acrylic acid" refers to at least one selected from the group consisting of acrylic acid and methacrylic acid. Notations such as "(meth)acryloyl" and "(meth)acrylate" have the same meaning.
[0111] Among these, the photopolymerizable compound (C) is preferably a polymerizable compound having three or more ethylenically unsaturated bonds. Examples of such polymerizable compounds include, for instance, trimethylolpropane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, pentaerythritol tetra(meth)acrylate, dipentaerythritol penta(meth)acrylate, dipentaerythritol hexa(meth)acrylate, tripentaerythritol octa(meth)acrylate, tripentaerythritol hepta(meth)acrylate, tetrapentaerythritol deca(meth)acrylate, tetrapentaerythritol nona(meth)acrylate, tris(2-(meth)acryloyloxyethyl)isocyanurate, ethylene glycol-modified pentaerythritol tetra(meth)acrylate, ethylene glycol-modified dipentaerythritol hexa(meth)acrylate, and propylene glycol-modified Examples include pentaerythritol tetra(meth)acrylate, propylene glycol-modified dipentaerythritol hexa(meth)acrylate, caprolactone-modified pentaerythritol tetra(meth)acrylate, caprolactone-modified dipentaerythritol hexa(meth)acrylate, etc.
[0112] The weight-average molecular weight of the photopolymerizable compound (C) is preferably 150 or more and 2900 or less, more preferably 250 or more and 1500 or less.
[0113] The content of the photopolymerizable compound (C) in the curable resin composition is preferably, for example, 7 mass% or more and 60 mass% or less with respect to the total amount of solids of the curable resin composition, more preferably 10 mass% or more and 45 mass% or less, and even more preferably 13 mass% or more and 30 mass% or less. When the content of the photopolymerizable compound (C) is within the above range, the residual film rate of the cured pattern and the chemical resistance of the cured pattern tend to be further improved.
[0114] [4] Photopolymerization initiator (D)
[0115] The photopolymerization initiator (D) is a compound capable of generating active radicals, acids, etc., and initiating polymerization by the action of light or heat, and may include at least one selected from the group consisting of oxime compounds, non-imidazole compounds, triazine compounds, and acylphosphine compounds. Among these, it is preferable to include at least one of an oxime compound and an acylphosphine compound. When using these polymerization initiators, the residual film rate of the curing pattern increases. When using the above photopolymerization initiator, there is a tendency to obtain a film in which the amount of outgassing released by heating is reduced. In addition, when using the above photopolymerization initiator, there is a tendency to obtain a film that exhibits excellent solvent resistance.
[0116] In addition, the above oxime compound, nonimidazole compound, triazine compound, and acylphosphine compound are preferably compounds having at least two aromatic rings in their molecule, as they tend to have a higher polymerization sensitivity when manufacturing a cured film.
[0117] Examples of aromatic rings include five-membered rings such as furan rings, pyrrole rings, imidazole rings, thiophene rings, and thiazole rings, six-membered rings such as benzene rings, pyridine rings, pyrimidine rings, and triazine rings, and condensed rings thereof.
[0118] The oxime compound is preferably an O-acyloxime compound and is a compound having a partial structure represented by formula (d1). Hereinafter, * indicates a bond loss.
[0119] [Chemical Formula 3]
[0120]
[0121] As oxime compounds, for example, N-benzoyloxy-1-(4-phenylsulfanylphenyl)butan-1-one-2-imine, N-benzoyloxy-1-(4-phenylsulfanylphenyl)octan-1-one-2-imine, N-benzoyloxy-1-(4-phenylsulfanylphenyl)-3-cyclopentylpropan-1-one-2-imine, N-acetoxy-1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazole-3-yl]ethane-1-imine, N-acetoxy-1-[9-ethyl-6-{2-methyl-4-(3,3-dimethyl-2,4-dioxacyclofentanylmethyloxy)benzoyl}-9H-carbazole-3-yl]ethane-1-imine, Examples include N-acetoxy-1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazole-3-yl]-3-cyclopentylpropane-1-imine, N-benzoyloxy-1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazole-3-yl]-3-cyclopentylpropane-1-one-2-imine; compounds described in Japanese Patent Publication No. 2011-132215, International Publication No. 2008 / 78678, International Publication No. 2008 / 78686, and International Publication No. 2012 / 132558. Commercial products such as Irgacure OXE01, OXE02 (both manufactured by BASF), and N-1919 (manufactured by ADEKA) may also be used.
[0122] Among these, at least one oxime compound selected from the group consisting of N-benzoyloxy-1-(4-phenylsulfanylphenyl)butan-1-one-2-imine, N-benzoyloxy-1-(4-phenylsulfanylphenyl)octan-1-one-2-imine, and N-benzoyloxy-1-(4-phenylsulfanylphenyl)-3-cyclopentylpropan-1-one-2-imine is preferred, and N-benzoyloxy-1-(4-phenylsulfanylphenyl)octan-1-one-2-imine is more preferred.
[0123] The non-imidazole compound is, for example, a compound represented by formula (d5).
[0124] [Chemical Formula 4]
[0125]
[0126] [In equation (d5), R 51 ~R 56 [It represents an aryl group having 6 to 10 carbon atoms that may have substituents.]
[0127] Examples of aryl groups having 6 to 10 carbon atoms include phenyl groups, toluyl groups, xylyl groups, ethylphenyl groups, and naphthyl groups, and preferably phenyl groups.
[0128] Examples of substituents include halogen atoms, carbon-1 to carbon-4 alkoxy groups, etc. Examples of halogen atoms include fluorine atoms, chlorine atoms, bromine atoms, iodine atoms, etc., and preferably chlorine atoms. Examples of carbon-1 to carbon-4 alkoxy groups include methoxy groups, ethoxy groups, propoxy groups, butoxy groups, etc., and preferably methoxy groups.
[0129] As nonimidazole compounds, for example, 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetraphenylbiimidazole, 2,2'-bis(2,3-dichlorophenyl)-4,4',5,5'-tetraphenylbiimidazole (see, for example, Japanese Patent Publication No. JP 06-75372, Japanese Patent Publication No. JP 06-75373, etc.), 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetraphenylbiimidazole, 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetra(alkoxyphenyl)biimidazole, 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetra(dialkoxyphenyl)biimidazole, Examples include 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetra(trialkoxyphenyl)biimidazole (e.g., see Japanese Patent Publication No. 48-38403, Japanese Patent Publication No. 62-174204, etc.), and imidazole compounds in which a phenyl group at the 4,4' 5,5'- position is substituted by a carboalkoxy group (e.g., see Japanese Patent Publication No. 7-10913, etc.). Among these, compounds represented by the following formula or mixtures thereof are preferred.
[0130] [Chemical Formula 5]
[0131]
[0132] As triazine compounds, for example, 2,4-bis(trichloromethyl)-6-(4-methoxyphenyl)-1,3,5-triazine, 2,4-bis(trichloromethyl)-6-(4-methoxynaphthyl)-1,3,5-triazine, 2,4-bis(trichloromethyl)-6-piperonyl-1,3,5-triazine, 2,4-bis(trichloromethyl)-6-(4-methoxystyryl)-1,3,5-triazine, 2,4-bis(trichloromethyl)-6-〔2-(5-methylfuran-2-yl)ethenyl〕-1,3,5-triazine, 2,4-bis(trichloromethyl)-6-〔2-(furan-2-yl)ethenyl〕-1,3,5-triazine, Examples include 2,4-bis(trichloromethyl)-6-[2-(4-diethylamino-2-methylphenyl)ethenyl]-1,3,5-triazine, 2,4-bis(trichloromethyl)-6-[2-(3,4-dimethoxyphenyl)ethenyl]-1,3,5-triazine. Among these, 2,4-bis(trichloromethyl)-6-piperonyl-1,3,5-triazine is preferred.
[0133] Examples of acylphosphine compounds include bis(2,4,6-trimethylbenzoyl)phenylphosphine oxide and (2,4,6-trimethylbenzoyl)diphenylphosphine oxide.
[0134] The photopolymerization initiator described above may be used alone or in combination with two or more photopolymerization initiators. When two or more photopolymerization initiators are used in combination, they may be combined with known polymerization initiators other than the oxime compounds, non-imidazole compounds, triazine compounds, and acylphosphine compounds described above.
[0135] Examples of known photopolymerization initiators include benzoin compounds such as benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, and benzoin isobutyl ether; benzophenone compounds such as benzophenone, o-benzoylbenzoate methyl, 4-phenylbenzophenone, 4-benzoyl-4'-methyldiphenyl sulfide, 3,3',4,4'-tetra(tert-butylperoxycarbonyl)benzophenone, 2,4,6-trimethylbenzophenone, and 4,4'-bis(diethylamino)benzophenone; quinone compounds such as 9,10-phenanthrenquinone, 2-ethylanthraquinone, and camphorquinone; and 10-butyl-2-chloroacridone, benzyl, methyl phenylglyoxylate, and titanocene compounds.
[0136] In addition, as other photopolymerization initiators, for example, 2,4,6-trimethylbenzoyldiphenylphosphine oxide (Speedcure TPO, manufactured by LAMBSON), 2,4,6-trimethylbenzoylphenylethoxyphosphine oxide, bis(2,4,6-trimethylbenzoyl)-phenylphosphine oxide (Omnirad 819, manufactured by IGM RESINS), bis(2,6-dimethoxybenzoyl)-2,4,4-trimethyl-pentylphosphine oxide, 2-hydroxy-2-methyl-[4-(1-methylvinyl)phenyl]propanol oligomer (Esacure ONE; manufactured by Lambert), 2,2-dimethoxy-2-phenylacetophenone (Omnirad 651; manufactured by IGM RESINS), Examples include amines such as 2-methyl-1-[4-(methylthio)phenyl]-2-morpholinopropan-1-one (Omnirad 907, manufactured by IGM RESINS), 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)-butan-1-one (Omnirad 369, manufactured by IGM RESINS), 2-chlorothioxantone, 2,4-dimethylthioxantone, 2,4-diisopropylthioxantone, isopropylthioxantone, benzoic acid 2-dimethylaminoethyl ester, dimethylaminoacetophenone, p-dimethylaminobenzoic acid ethyl ester or p-dimethylaminobenzoic acid isoamyl ester. Among other polymerization initiators, preferably 2-methyl-1-[4-(methylthio)phenyl]-2-morpholinopropan-1-one (Omnirad 907, manufactured by IGM Resins B.).
[0137] Examples of combinations of two or more photopolymerization initiators include combinations of an oxime compound and a non-imidazole compound, an oxime compound and a triazine compound, an oxime compound and an acylphosphine compound, a nonimidazole compound and a triazine compound, a nonimidazole compound and an acylphosphine compound, and a triazine compound and an acylphosphine compound.
[0138] [Photopolymerization Initiation Agent (D1)]
[0139] Additionally, if necessary, a photopolymerization initiation agent (D1) may be used in combination. The photopolymerization initiation agent (D1) is a compound or sensitizer used to promote the polymerization of a photopolymerizable compound whose polymerization has been initiated by a photopolymerization initiator, and when the photopolymerization initiation agent (D1) is included, it is typically used in combination with the photopolymerization initiator. Examples of photopolymerization initiation agents (D1) include amine compounds, alkoxyanthracene compounds, thioxantone compounds, and carboxylic acid compounds.
[0140] Examples of amine compounds include triethanolamine, methyldiethanolamine, triisopropanolamine, methyl 4-dimethylaminobenzoate, ethyl 4-dimethylaminobenzoate, isoamyl 4-dimethylaminobenzoate, 2-dimethylaminoethyl benzoate, 2-ethylhexyl 4-dimethylaminobenzoate, N,N-dimethylparatoluidine, 4,4'-bis(dimethylamino)benzophenone (commonly known as Mihiler ketone), 4,4'-bis(diethylamino)benzophenone, and 4,4'-bis(ethylmethylamino)benzophenone, among others; among these, 4,4'-bis(diethylamino)benzophenone is preferred. Commercial products such as EAB-F (manufactured by Hodogaya Chemical Industry Co., Ltd.) may also be used.
[0141] Examples of alkoxianthracene compounds include 9,10-dimethoxycyanthracene, 2-ethyl-9,10-dimethoxycyanthracene, 9,10-diethoxycyanthracene, 2-ethyl-9,10-diethoxycyanthracene, 9,10-dibutoxycyanthracene, and 2-ethyl-9,10-dibutoxycyanthracene.
[0142] Examples of thioxantone compounds include 2-isopropylthioxantone, 4-isopropylthioxantone, 2,4-diethylthioxantone, 2,4-dichlorothioxantone, 1-chloro-4-propoxythioxantone, etc.
[0143] Examples of carboxylic acid compounds include phenylsulfanylacetic acid, methylphenylsulfanylacetic acid, ethylphenylsulfanylacetic acid, methylethylphenylsulfanylacetic acid, dimethylphenylsulfanylacetic acid, methoxyphenylsulfanylacetic acid, dimethoxyphenylsulfanylacetic acid, chlorophenylsulfanylacetic acid, dichlorophenylsulfanylacetic acid, N-phenylglycine, phenoxyacetic acid, naphthylthioacetic acid, N-naphthylglycine, and naphthoxyacetic acid.
[0144] The content of the photopolymerization initiator (D) is preferably 0.1 parts by mass or more and 300 parts by mass or less, and more preferably 0.1 parts by mass or more and 200 parts by mass or less, with respect to 100 parts by mass of the photopolymerizable compound (C). The content of the photopolymerization initiator (D) is preferably 0.1 parts by mass or more and 30 parts by mass or less, and more preferably 1 part by mass or more and 20 parts by mass or less, with respect to 100 parts by mass of the total amount of resin (B) and photopolymerizable compound (C). When the content of the photopolymerization initiator (D) is within the above range, the productivity of the cured film is improved because the sensitivity tends to be increased and the exposure time is shortened.
[0145] In addition, when a photopolymerization initiation agent (D1) is included, the content of the photopolymerization initiation agent (D1) is preferably 0.1 parts by mass or more and 300 parts by mass or less, and more preferably 0.1 parts by mass or more and 200 parts by mass or less, with respect to 100 parts by mass of the photopolymerizable compound (C). The content of the photopolymerization initiator (D) is preferably 0.1 parts by mass or more and 30 parts by mass or less, and more preferably 1 part by mass or more and 20 parts by mass or less, with respect to 100 parts by mass of the total amount of the resin (B) and the photopolymerizable compound (C). If the amount of the photopolymerization initiation agent (D1) is within this range, there is a tendency to form a cured film with higher sensitivity.
[0146] [5] Antioxidant (E)
[0147] As for the antioxidant (E), there are no particular limitations on any antioxidant that is generally used industrially, and phenolic antioxidants, phosphorus-based antioxidants, phosphorus / phenol complex antioxidants, and sulfur-based antioxidants may be used. Two or more types of antioxidants (E) may be used in combination. The phosphorus / phenol complex antioxidant may be a compound having at least one phosphorus atom and one or more phenol structures in its molecule. Among these, the phosphorus / phenol complex antioxidant is preferred from the perspective of developability and luminescence intensity. In addition, when using the phosphorus / phenol complex antioxidant, it tends to be easier to obtain a film in which the amount of outgassing released upon heating is reduced. In addition, when using the phosphorus / phenol complex antioxidant, it tends to be easier to obtain a film that exhibits excellent solvent resistance.
[0148] As phenolic antioxidants, for example, Irganox (registered trademark) 1010 (Irganox 1010: pentaerythritol tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionate], manufactured by BASF, Inc.), the same 1076 (Irganox 1076: octadecyl-3-(3,5-di-t-butyl-4-hydroxyphenyl)propionate, manufactured by BASF, Inc.), the same 1330 (Irganox 1330: 3,3',3'',5,5',5''-hexa-t-butyl-a,a',a''-(mesitylene-2,4,6-triyl)tri-p-cresol, manufactured by BASF, Inc.), and the same 3114 (Irganox 3114: 1,3,5-Tris(3,5-di-t-butyl-4-hydroxybenzyl)-1,3,5-Triazine-2,4,6(1H,3H,5H)-Trione, Manufactured by BASF), the same 3790 (Irganox 3790: 1,3,5-Tris((4-t-butyl-3-hydroxy-2,6-xylyl)methyl)-1,3,5-Triazine-2,4,6(1H,3H,5H)-Trione, Manufactured by BASF), the same 1035 (Irganox 1035: Thiodiethylenebis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate], Manufactured by BASF), the same 1135 (Irganox 1135: Benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy, C7-C9 side-chain alkyl ester, manufactured by BASF), the same 1520L (Irganox 1520L: 4,6-bis(octylthiomethyl)-o-cresol, manufactured by BASF), the same 3125 (Irganox 3125, manufactured by BASF), the same 565 (Irganox 565: 2,4-bis(n-octylthio)-6-(4-hydroxy 3',5'-di-t-butylanilino)-1,3,5-triazine, manufactured by BASF), Adecastav (registered trademark) AO-80 (Adecastav AO-80: 3,9-Bis(2-(3-(3-t-butyl-4-hydroxy-5-methylphenyl)propionyloxy)-1,1-dimethylethyl)-2,4,8,10-tetraoxaspiro(5,5)undecane, manufactured by ADEKA Corp.), Smilizer (registered trademark) BHT, the same GA-80, the same GS (all above, manufactured by Sumitomo Chemical Corp.),Examples include Cyanox (registered trademark) 1790 (Cyanox 1790, manufactured by Cytech Co., Ltd.) and Vitamin E (manufactured by Eizai Co., Ltd.).
[0149] As phosphorus-based antioxidants, for example, Irgafos (registered trademark) 168 (tris(2,4-di-t-butylphenyl)phosphite, manufactured by BASF, Ltd.), Irgafos 12 (tris[2-[[2,4,8,10-tetra-t-butyldibenzo[d,f][1,3,2]dioxaphosphine-6-yl]oxy]ethyl]amine, manufactured by BASF, Ltd.), Irgafos 38 (bis(2,4-bis(1,1-dimethylethyl)-6-methylphenyl)ethyl ester phosphoric acid, manufactured by BASF, Ltd.), Adecastab (registered trademark) 329K, PEP36, and PEP-8 (all manufactured by ADEKA, Ltd.), Sandstab P-EPQ (manufactured by Clariant), and Weston (registered trademark). Examples include 618, 619G (both manufactured by GE), and Ultranox 626 (manufactured by GE).
[0150] Examples of phosphorus / phenol complex type antioxidants include Smilizer (registered trademark) GP (6-[3-(3-t-butyl-4-hydroxy-5-methylphenyl)propoxy]-2,4,8,10-tetra-t-butyldibenz[d,f][1.3.2]dioxaphospherine) (manufactured by Sumitomo Chemical Corporation).
[0151] Examples of sulfur-based antioxidants include dialkylthiodipropionate compounds such as dilauryl, dimyristyl, or distearyl thiodipropionate, and β-alkylmercaptopropionate ester compounds of polyols such as tetrakis[methylene(3-dodecylthio)propionate]methane.
[0152] The content of the antioxidant (E) may be, for example, 1 part by mass or more and 50 parts by mass or less per 100 parts by mass of the resin (B), and, from the perspective of luminescence amount and heat resistance, preferably 5 parts by mass or more and 40 parts by mass or less, more preferably 7 parts by mass or more and 30 parts by mass or less, and even more preferably 11 parts by mass or more and 25 parts by mass or less.
[0153] [6] Leveling agent (F)
[0154] Examples of leveling agents (F) include silicone-based surfactants, fluorine-based surfactants, and silicone-based surfactants having fluorine atoms. These may have polymerizable groups in their side chains. From the perspective of developability and luminescence intensity, it is preferable that the leveling agent (F) be a fluorine-based surfactant or a silicone-based surfactant.
[0155] Examples of silicone-based surfactants include surfactants having siloxane bonds within the molecule. Specifically, examples include Toray Silicon DC3PA, SH7PA, DC11PA, SH21PA, SH28PA, SH29PA, SH30PA, SH8400 (product name: manufactured by Toray Dow Corning Co., Ltd.), KP321, KP322, KP323, KP324, KP326, KP340, KP341 (manufactured by Shin-Etsu Chemical Co., Ltd.), TSF400, TSF401, TSF410, TSF4300, TSF4440, TSF4445, TSF4446, TSF4452, and TSF4460 (manufactured by Momentive Performance Materials Japan).
[0156] Examples of fluorine-based surfactants include surfactants having a fluorocarbon chain within the molecule. Specifically, examples include Florad (registered trademark) FC430, FC431 (manufactured by Sumitomo 3M Inc.), Megapak (registered trademark) F142D, F171, F172, F173, F177, F183, F554, F575, R30, RS-718-K (manufactured by DIC Inc.), F-Top (registered trademark) EF301, EF303, EF351, EF352 (manufactured by Mitsubishi Materials Electronic Chemicals Inc.), Surfron (registered trademark) S381, S382, SC101, SC105 (manufactured by Asahi Glass Inc.), and E5844 (manufactured by Daikin Fine Chemical Research Institute Inc.).
[0157] Examples of silicone-based surfactants having fluorine atoms include surfactants having siloxane bonds and fluorocarbon chains within the molecule. Specifically, examples include MegaPac (registered trademark) R08, BL20, F475, F477, and F443 (manufactured by DIC Co., Ltd.).
[0158] The content of the leveling agent (F) may be, for example, 0.001 mass% or more and 1.0 mass% or less with respect to the total amount of the curable resin composition, preferably 0.005 mass% or more and 0.75 mass% or less, more preferably 0.01 mass% or more and 0.5 mass% or less, and even more preferably 0.05 mass% or more and 0.5 mass% or less. If the content of the leveling agent (F) is within the above range, the flatness of the cured film can be improved.
[0159] [7] Solvent (G)
[0160] The solvent (G) is not particularly limited as long as it dissolves the resin (B), the photopolymerizable compound (C), and the photopolymerization initiator (D), and any solvent commonly used in the field may be used. Examples include ester solvents (solvents containing -COO- in the molecule and not -O-), ether solvents (solvents containing -O- in the molecule and not -COO-), ether ester solvents (solvents containing -COO- and -O- in the molecule), ketone solvents (solvents containing -CO- in the molecule and not -COO-), alcohol solvents (solvents containing OH in the molecule and not -O-, -CO-, and COO-), aromatic hydrocarbon solvents, amide solvents, dimethyl sulfoxide, etc.
[0161] Examples of ester solvents include methyl lactate, ethyl lactate, n-butyl lactate, 2-methyl hydroxyisobutanoate, ethyl acetate, n-butyl acetate, isobutyl acetate, n-pentyl formate, isopentyl acetate, n-butyl propionate, isopropyl butyrate, ethyl butyrate, n-butyl butyrate, methyl pyruvate, ethyl pyruvate, propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, cyclohexanol acetate, and γ-butyrolactone.
[0162] Examples of ether solvents include ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, ethylene glycol monobutyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monopropyl ether, propylene glycol monobutyl ether, 3-methoxy-1-butanol, 3-methoxy-3-methylbutanol, tetrahydrofuran, tetrahydropyran, 1,4-dioxane, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol methyl ethyl ether, diethylene glycol dipropyl ether, diethylene glycol dibutyl ether, anisole, phenetol, and methylanisole.
[0163] As ether ester solvents, methyl methoxyacetate, ethyl methoxyacetate, butyl methoxyacetate, methyl ethoxyacetate, ethyl ethoxyacetate, 3-methyl methoxypropionate, 3-ethyl methoxypropionate, 3-methyl methoxypropionate, 3-ethyl ethoxypropionate, 2-methyl methoxypropionate, 2-ethyl methoxypropionate, 2-propyl methoxypropionate, 2-methyl ethoxypropionate, 2-ethyl ethoxypropionate, 2-methyl-2-methylpropionate, 2-ethoxy-2-ethylpropionate, 3-methoxybutyl acetate, 3-methyl-3-methoxybutyl acetate, propylene glycol monomethyl ether acetate, Examples include propylene glycol monoethyl ether acetate, propylene glycol monopropyl ether acetate, ethylene glycol monomethyl ether acetate, ethylene glycol monoethyl ether acetate, diethylene glycol monoethyl ether acetate, and diethylene glycol monobutyl ether acetate.
[0164] Examples of ketone solvents include 4-hydroxy-4-methyl-2-pentanone, acetone, 2-butanone, 2-heptanone, 3-heptanone, 4-heptanone, 4-methyl-2-pentanone, cyclopentanone, cyclohexanone, and isophorone.
[0165] Examples of alcohol solvents include methanol, ethanol, propanol, butanol, hexanol, cyclohexanol, ethylene glycol, propylene glycol, and glycerin.
[0166] Examples of aromatic hydrocarbon solvents include benzene, toluene, xylene, and mesitylene.
[0167] Examples of amide solvents include N,N-dimethylformamide, N,N-dimethylacetamide, and N-methylpyrrolidone.
[0168] As a solvent, propylene glycol monomethyl ether acetate, ethyl lactate, propylene glycol monomethyl ether, ethyl 3-ethoxypropionate, ethylene glycol monomethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, 4-hydroxy-4-methyl-2-pentanone, or toluene are preferred.
[0169] The solvent (G) is a component other than the solid content, and is a component that includes, for example, a solvent contained in the quantum dot (A) or resin (B). The content of the solvent (G) is the ratio of the total mass of all solvents contained in the composition to the total amount of the composition, and with respect to the total amount of the curable resin composition, it may be, for example, 40 mass% or more and 95 mass% or less, and preferably 55 mass% or more and 90 mass% or less. In other words, the solid content of the curable resin composition is preferably 5 mass% or more and 60 mass% or less, more preferably 10 mass% or more and 45 mass% or less. If the content of the solvent (G) is within the above range, the flatness of the composition layer during application becomes better, and there is a tendency to form a cured film of appropriate thickness.
[0170] [8] Light scattering agent (H)
[0171] The curable resin composition of the present invention may further contain a light-scattering agent (H). Examples of the light-scattering agent (H) include particles of a metal or metal oxide, glass particles, etc. Examples of metal oxides include TiO2, SiO2, BaTiO3, ZnO, etc. The particle size of the light-scattering agent (H) is, for example, 0.03 μm or more and 20 μm or less, preferably 0.05 μm or more and 1 μm or less, more preferably 0.05 μm or more and 0.5 μm or less.
[0172] The content of the light-scattering agent (H) in the curable resin composition may be, for example, 0.001 mass% or more and 50 mass% or less with respect to the total amount of solids of the curable resin composition, preferably 1 mass% or more and 30 mass% or less, and more preferably 2 mass% or more and 10 mass% or less, from the perspective of developability and luminescence intensity. When the curable composition contains an organic solvent, the light-scattering agent (H) may be used in which it has been pre-dispersed in a portion of the organic solvent (G) using a dispersant (J). Commercially available products may be used as the dispersant (J). Examples of commercially available products include,
[0173] DISPERBYK-101, 102, 103, 106, 107, 108, 109, 110, 111, 116, 118, 130, 140, 154, 161, 162, 163, 164, 165, 166, 170, 171, 174, 180, 181, 182, 183, 184, 185, 190, 192, 2000, 2001, 2020, 2025, 2050, 2070, 2095, 2150, 2155; ANTI-TERRA-U, U100, 203, 204, 250, ; BYK-P104, P104S, P105, 220S, 6919; BYK-LPN6919, 21116; LACTIMON, LACTIMON-WS; Bykumen et al.;
[0174] SOLSPERSE-3000, 9000, 13000, 13240, 13650, 13940, 16000, 17000, 18000, 20000, 21000, 24000, 26000, 27000, 28000, 31845, 32000, 32500, 32550, 33500, 32600, 34750, 35100, 36600, 38500, 41000, 41090, 53095, 55000, 76500, etc. from Lubrizol Inc. of Japan;
[0175] BASF Proposal EFKA-46, 47, 48, 452, 4008, 4009, 4010, 4015, 4020, 4047, 4050, 4055, 4060, 4080, 4400, 4401, 4402, 4403, 4406, 4408, 4300, 4310, 4320, 4330, 4340, 450, 451, 453, 4540, 4550, 4560, 4800, 5010, 5065, 5066, 5070, 7500, 7554, 1101, 120, 150, 1501, 1502, 1503, etc.;
[0176] Ajispa PA111, PB711, PB821, PB822, PB824 proposed by Ajinomoto Fine Techno
[0177] You can lift the back.
[0178] In addition, the curable resin composition of the present invention may additionally include additives known in the art, such as polymerization inhibitors, fillers, other polymer compounds, adhesion promoters, light stabilizers, and chain transfer agents, as needed.
[0179] Method for manufacturing a curable resin composition
[0180] A method for manufacturing a curable resin composition may include a process of mixing a quantum dot (A), a resin (B), a polymerizable compound (C), a photopolymerization initiator (D), an antioxidant (E), a leveling agent (F), a solvent (G), and other components used as needed.
[0181] The method for preparing a curable resin composition of the present invention may include a process of preparing a resin (B). The obtained resin (B) may not contain either an aliphatic tertiary amine compound or an aliphatic quaternary ammonium salt compound, or may contain less than 0.8 mass% of at least one of the aliphatic tertiary amine compound and the aliphatic quaternary ammonium salt compound relative to the total amount of solids of the resin (B). In the process of preparing the resin (B), preferably, in terms of development time and luminescence intensity, an amine compound is not used as a reaction catalyst.
[0182] Hardened film >
[0183] The cured film of the present invention can be obtained by applying the curable resin composition of the present invention to a substrate and curing it through the action of light or heat. The cured film of the present invention may be formed on the entire surface of the substrate or may be formed on a part of the substrate (i.e., a cured pattern). Methods for forming the cured film on a part of the substrate include photolithography, inkjet printing, and printing. Among these, photolithography is preferred. Photolithography is a method of applying the curable resin composition of the present invention to a substrate, drying it as needed to form a composition layer, and exposing the composition layer to light through a photomask to develop it.
[0184] A method for forming a cured film on the entire surface of a substrate may include applying the curable resin composition of the present invention to a substrate, drying it as needed to form a composition layer, and heating the composition layer and / or exposing the entire surface of the composition layer to light.
[0185] Examples of substrates include glass plates such as quartz glass, borosilicate glass, alumina silicate glass, and soda-lime glass with a silica-coated surface, resin plates such as polycarbonate, polymethyl methacrylate, and polyethylene terephthalate, silicon, and thin films of aluminum, silver, and silver / copper / palladium alloy formed on the substrate.
[0186] The formation of a cured pattern by photolithography can be carried out using known or conventional devices or conditions. For example, it can be produced as follows.
[0187] First, a curable composition is applied onto a substrate, and volatile components such as solvents are removed by heat drying (prebaking) and / or vacuum drying to obtain a composition layer. Examples of application methods include spin coating, slit coating, and slit-and-spin coating.
[0188] When performing heat drying, the temperature is preferably 30 to 120°C, and more preferably 50 to 110°C. Also, the heating time is preferably 10 seconds to 60 minutes, and more preferably 30 seconds to 30 minutes.
[0189] When performing vacuum drying, it is preferable to do so under a pressure of 50 to 150 Pa and in a temperature range of 20 to 25°C.
[0190] The film thickness of the composition layer is not particularly limited and can be appropriately selected according to the film thickness of the desired curing pattern, for example, it may be 0.5 μm or more and 20 μm or less, preferably 3 μm or more and 18 μm or less, more preferably 5 μm or more and 16 μm or less.
[0191] Next, the composition layer is exposed via a photomask to form a desired curing pattern. The pattern on the photomask is not particularly limited.
[0192] As a light source used for exposure, a light source that generates light with a wavelength of 250 to 450 nm is preferred. For example, from the light of the said wavelength, light around 436 nm, around 408 nm, or around 365 nm may be selectively extracted using a bandpass filter depending on the absorption wavelength of the polymerization initiator. Specifically, examples include mercury lamps, light-emitting diodes, metal halide lamps, halogen lamps, etc.
[0193] It is preferable to use an exposure device such as a mask aligner and a stepper, as this allows for uniformly irradiating parallel light rays across the entire exposure surface or performing accurate positional alignment between the photomask and the substrate on which the composition layer is formed. The exposed composition layer is cured by polymerizing a polymerizable compound, etc., included in the composition layer.
[0194] By contacting the composition layer after exposure with a developer solution and developing it, the unexposed portion of the composition layer is dissolved in the developer solution and removed, thereby obtaining a cured pattern. Examples of the developer solution include an aqueous solution of an alkaline compound such as potassium hydroxide, sodium bicarbonate, sodium carbonate, or tetramethylammonium hydroxide, or an organic solvent. The concentration of the alkaline compound in the aqueous solution is preferably 0.01 mass% or more and 10 mass% or less, and more preferably 0.03 mass% or more and 5 mass% or less. As for the organic solvent, the same as the solvent (G) described above may be used. In addition, the developer solution may contain a surfactant.
[0195] The development method may be any of the following: paddle method, dipping method, or spray method. Additionally, the substrate may be tilted at any angle during development.
[0196] It is preferable to perform additional heating (post-baking) on the cured pattern obtained by development. The heating temperature is preferably 150 to 250°C, and more preferably 160 to 235°C. The heating time is preferably 1 to 120 minutes, and more preferably 10 to 60 minutes. By performing heating after development, polymerization of unreacted polymerizable compounds, etc., contained in the cured pattern can be carried out, so a cured pattern with better chemical resistance can be obtained.
[0197] By irradiating the cured film with ultraviolet light or visible light, the cured film of the present invention can emit light of a wavelength different from the irradiated light. By selecting the component or particle size of the quantum dots in the curable resin composition used to form the cured film of the present invention, the wavelength of the emitted light can be selected.
[0198] As the cured film of the present invention has the function of converting the wavelength of irradiated light as described above, it can be used as a color conversion layer of a display device. Examples of such display devices include those described in Japanese Patent Publication No. 2006-309219, Japanese Patent Publication No. 2006-310303, Japanese Patent Publication No. 2013-15812, Japanese Patent Publication No. 2009-251129, Japanese Patent Publication No. 2014-2363, etc.
[0199] The cured film of the present invention can easily reduce the amount of outgassing emitted when heated. The amount of outgassing can be evaluated according to the method described in the section of the examples below, using the weight change rate (%) [=([weight after heating] / [weight before heating])×100] when the cured film is heated at 180°C for 60 minutes. The cured film of the present invention may have the weight change rate (%) be, for example, 1% or less, or 0.5% or less. From the perspective of making it easier to reduce contamination of the device in subsequent processes, it is preferably 0.8% or less, more preferably 0.6% or less, even more preferably 0.4% or less, particularly preferably 0.2% or less, typically 0% or more, and for example, 0.01% or more or 0.05% or more.
[0200] The cured film of the present invention can exhibit excellent solvent resistance. Solvent resistance can be evaluated according to the method described in the section on examples, using the rate of change in luminescence intensity when the cured film is immersed in propylene glycol monomethyl ether acetate (PGMEA) for 30 minutes. The rate of change in luminescence intensity of the cured film of the present invention may be, for example, 88% or more, preferably 90% or more, more preferably 92% or more, even more preferably 94% or more, particularly preferably 96% or more, even more particularly preferably 98% or more, and typically 100% or less.
[0201] It is preferable that the cured film of the present invention has a weight change rate (%) of 0.8% or less when heated at 180°C for 60 minutes, and a change rate in luminescence intensity of 92% or more when the cured film is immersed in PGMEA for 30 minutes. It is also preferable that the cured film of the present invention has a weight change rate (%) of 0.4% or less when heated at 180°C for 60 minutes, and a change rate in luminescence intensity of 88% or more when the cured film is immersed in PGMEA for 30 minutes. Furthermore, it is particularly preferable that the cured film of the present invention has a weight change rate (%) of 0.4% or less when heated at 180°C for 60 minutes, and a change rate in luminescence intensity of 92% or more when the cured film is immersed in PGMEA for 30 minutes.
[0202] The curable resin composition of the present invention is useful as a color conversion layer for display devices, particularly liquid crystal display devices, because it tends to produce a film with a fast development speed even when the film is thick and also has a high luminescence intensity.
[0203] Examples
[0204] The present invention will be explained in more detail below through examples. In the examples, “%” and “parts” refer to mass % and mass parts, respectively, unless otherwise specifically stated.
[0205] [Evaluation of Phenomenality]
[0206] A curable resin composition was applied to a glass substrate (Eagle 2000; Corning) measuring 5 cm by 5 cm by spin coating to a film thickness of 10 μm, and then pre-baked at 100°C for 3 minutes to form a curable resin composition layer. The substrate was then immersed in a developer (0.05% aqueous potassium hydroxide solution) and developed. The time required for the curable resin composition layer to be completely removed was measured.
[0207] [Measurement of Luminous Intensity]
[0208] A curable resin composition was applied to a glass substrate (Eagle 2000; manufactured by Corning) with dimensions of 5 cm by 5 cm using a spin coating method to a film thickness of 10 μm, and then pre-baked at 100°C for 3 minutes to form a curable composition layer. On the substrate having the curable composition layer formed thereon, light was irradiated using an exposure device (TME-150RSK; manufactured by Topcon Co., Ltd.) under an atmospheric environment with an exposure amount of 80 mJ / cm² (based on 365 nm), and after development, a substrate having a cured film was obtained by performing a post-bak at 180°C for 60 minutes.
[0209] A narrow-direction type sensing backlight illumination (OPF series; manufactured by Offtex FA) equipped with an LED lamp having an emission wavelength of 444 nm and a scratch-resistant cover was prepared as a backlight. The backlight was mounted with the scratch-resistant cover facing upward, and a black film with holes was installed on the scratch-resistant cover to prevent light leakage other than at the measurement site. Then, an optical fiber for detecting light emission connected to the following spectrometer was installed at a height of 4 cm from the surface of the scratch-resistant cover. A glass substrate (Eagle 2000; manufactured by Corning) was placed on the surface of the scratch-resistant cover of the backlight as a reference. In this state, the backlight was turned on, and the amount of light from the backlight was adjusted so that the total radiant flux (μW) of the backlight was 1500 μW over the reference glass substrate (Eagle 2000; Corning).
[0210] Next, a substrate having the cured film prepared above was placed on the surface of the glass substrate. In this state, a backlight was turned on, and the luminous intensity (unit: μW) was measured as the integrated radiant flux in the range of wavelengths from 485 nm to 780 nm for the light emitted from the cured film. A spectrometer (manufactured by Ocean Optics) was used to measure the luminous intensity.
[0211] [Method for Evaluating Outgases]
[0212] After preparing a cured film in the same manner as the above [measurement of luminescence intensity], the film portion (film thickness = 10 μm) was peeled off, and after holding at 180°C for 60 minutes using TGDTA [high-performance thermal analysis device NEXTA (registered trademark) STA200 (manufactured by Hitachi High-Tech Co., Ltd.)], the weight change rate (%) [=([weight after heating] / [weight before heating])×100] was calculated.
[0213] [Method of Evaluating Content]
[0214] After preparing a cured film in the same manner as the above [measurement of luminescence intensity], the film was immersed in PGMEA for 30 minutes. The luminescence intensity before and after immersion was measured, and the rate of change in luminescence intensity before and after immersion was calculated.
[0215] [Weight-average molecular weight]
[0216] The weight-average molecular weight (Mw) of the resin was measured by the GPC method under the following conditions.
[0217] Device; K2479 (Manufactured by Shimadzu Corporation)
[0218] Column; SHIMADZU Shim-pack GPC-80M
[0219] Column temperature; 40℃
[0220] Solvent; Tetrahydrofuran
[0221] Flow rate; 1.0 mL / min
[0222] Detector; RI
[0223] Calibration standard materials; TSK STANDARD POLYSTYRENE F-40, F-4, F-288, A-2500, A-500 (manufactured by Toso Co., Ltd.)
[0224] [Sanga]
[0225] 3 g of resin solution was weighed and dissolved in a mixed solvent of 90 g of acetone and 10 g of water. Using a 0.1 KOH aqueous solution as the titrator, the acid value of the polymer solution was measured using an automatic titration device (manufactured by Hiranuma Sangyo Co., Ltd., product name: COM-555), and the acid value per 1 g of solid (AV) was calculated from the acid value of the solution and the solid content of the solution.
[0226] [Solid Content]
[0227] Approximately 1 g of the polymer solution was placed in an aluminum cup, dried at 180°C for 1 hour, and then the mass was measured. From the amount of mass loss, the solid content (mass%) of the polymer solution was calculated.
[0228] [Content of aliphatic tertiary amine compounds and aliphatic quaternary ammonium salt compounds]
[0229] < Device Name, Measurement Condition >
[0230] Equipment Used: Thermo Fisher Scientific ICS-1500 Separation Column: IonPac CG14 + CS14 (4 mm)
[0231] Column temperature: 30℃
[0232] Eluent: 10 mM methanesulfonic acid
[0233] Flow rate: 1 mL / min Detector: Electrical conductivity detector
[0234] < Preprocessing Method >
[0235] 0.1 g of the sample was dissolved in THF and diluted to 10 mL with pure water. The solution was filtered, and the filtrate was further diluted with pure water to prepare the test solution.
[0236] Preparation Example 1: Quantum dot dispersion (A-1)
[0237] A toluene dispersion of InP / ZnSeS proton dots coordinated with oleic acid as a ligand was prepared. The dispersion was subjected to vacuum distillation to remove toluene. 70 parts of cyclohexyl acetate were added to 30 parts of solids to obtain a proton dot dispersion (A-1) (solids 30%).
[0238] Preparation Example 2: Light scattering agent (H-1)
[0239] 3 parts by mass of DISPERBYK21116 (manufactured by Big Chem Japan) as a solid and 100 parts by mass of PGMEA were added to 70 parts by mass of titanium oxide nanoparticles, and then stirred in a paint shaker until sufficiently dispersed to obtain a dispersion of a light scattering agent (H-1) (solid content 73%).
[0240] Synthetic Example 1: Resin (B-1)
[0241] 110 parts by mass of propylene glycol monomethyl ether acetate (hereinafter referred to as "PGMEA") was added to a flask equipped with a stirrer, a reflux condenser with a thermometer, a dropping funnel, and a nitrogen inlet tube, and then stirred while purging with nitrogen and raised to 80°C. 25 parts by mass of dicyclofentanyl methacrylate, 26 parts by mass of methyl methacrylate, 16 parts by mass of methacrylic acid, and 14 parts by mass of 2,2'-azobis(2,4-dimethylvaleronitrile) dissolved in 110 parts by mass of PGMEA was added dropwise from the dropping funnel into the flask, and then stirred at 80°C for 3 hours.
[0242] Next, 16 parts by mass of glycidyl methacrylate, 0.4 parts by mass of 2,2'-methylenebis(4-methyl-6-t-butylphenol), and 0.8 parts by mass of triphenylphosphine were added to a flask, heated to 110°C, and stirred for 8 hours to react the carboxylic acid with the epoxy group in the polymer, thereby introducing a polymerizable unsaturated bond. Subsequently, 17 parts by mass of 1,2,3,6-tetrahydrophthalic anhydride were added, and the reaction was continued for 3 hours to introduce carboxylic acid groups into the side chain. A resin (B-1) solution was obtained by cooling the reaction mixture to room temperature.
[0243] The resin (B-1) had a weight-average molecular weight of 5,200 and an acid value of 100 mgKOH / g, and the solid content in the resin (B-1) solution was 40 mass%.
[0244] Synthetic Example 2: Resin (B-2)
[0245] A resin (B-2) solution was prepared in the same manner as in Synthesis Example 1, except that 2,2'-azobis(2,4-dimethylvaleronitrile) was used in an amount of 12.5 parts by mass.
[0246] Synthetic Example 3: Resin (B-3)
[0247] A resin (B-3) solution was prepared in the same manner as in Synthesis Example 1, except that 2,2'-azobis(2,4-dimethylvaleronitrile) was used in parts by mass of 11.
[0248] Synthetic Example 4: Resin (B-4)
[0249] A resin (B-4) solution was prepared in the same manner as in Synthesis Example 1, except that methyl methacrylate was 23 parts by mass, methacrylic acid was 19 parts by mass, and 2,2'-azobis(2,4-dimethylvaleronitrile) was 10 parts by mass.
[0250] Synthetic Example 5: Resin (B-5)
[0251] 110 parts by mass of propylene glycol monomethyl ether acetate (hereinafter referred to as “PGMEA”) was added to a flask equipped with a stirrer, a reflux condenser with a thermometer, a dropping funnel, and a nitrogen inlet tube, and then stirred while purging with nitrogen and raised to 80°C. 25 parts by mass of dicyclofentanyl methacrylate, 21 parts by mass of methyl methacrylate, 26 parts by mass of methacrylic acid, and 10 parts by mass of 2,2'-azobis(2,4-dimethylvaleronitrile) dissolved in 110 parts by mass of PGMEA were added dropwise from the dropping funnel into the flask, and then stirred at 80°C for 3 hours.
[0252] Next, 16 parts by mass of glycidyl methacrylate, 0.4 parts by mass of 2,2'-methylenebis(4-methyl-6-t-butylphenol), and 0.8 parts by mass of triethylamine were added to a flask, heated to 110°C, and stirred for 8 hours to react the carboxylic acid with the epoxy group in the polymer, thereby introducing polymerizable unsaturated bonds. A resin (B-5) solution was obtained by cooling the reaction mixture to room temperature. The content of triethylamine in the resin (B-5) was 0.8% by mass relative to the total amount of solids in the resin (B-5).
[0253] Synthetic Example 6: Resin (B-6)
[0254] 150 parts by mass of propylene glycol monomethyl ether acetate was introduced into a flask equipped with a cooling tube and a stirrer, and nitrogen was substituted. The mixture was heated to 80°C, and at the same temperature, a mixed solution of 50 parts by mass of propylene glycol monomethyl ether acetate, 30 parts by mass of 2-methacryloyloxyethyl succinic acid, 10 parts by mass of benzyl methacrylate, 60 parts by mass of 2-ethylhexyl methacrylate, and 6 parts by mass of 2,2'-azobis(2,4-dimethylvaleronitrile) was added dropwise over 2 hours, and polymerization was carried out for 1 hour while maintaining the temperature. Afterward, the temperature of the reaction solution was raised to 90°C, and polymerization was carried out for an additional 1 hour to obtain a resin (B-6) solution. The resin (B-6) had an Mw = 11000 and an acid value = 70, and the solid content of the resin (B-6) solution was 33 mass%.
[0255] The weight-average molecular weight, molecular weight distribution, acid value, acrylic equivalent, and content of aliphatic tertiary amine and aliphatic quaternary ammonium salt compounds of resins (B-1) to (B-6) are shown in Table 1 below.
[0256] [Table 1]
[0257]
[0258] < Examples 1–9, Comparative Example 1 >
[0259] Curable resin compositions of the examples and comparative examples were prepared by mixing each component of Table 2. The luminescence intensity and development time of the obtained curable resin compositions were evaluated. The results are shown in Table 3.
[0260] [Table 2]
[0261]
[0262] Photopolymerizable compound (C-1): M-510 (polybasic modified acrylate, manufactured by Dong-A Synthetic Co.)
[0263] Photopolymerizable compound (C-2): A-9550 (Dipentaerythritol polyacrylate, manufactured by Shinnakamura Chemical Co.)
[0264] Photopolymerization initiator (D-1): Oxe01 (BASF)
[0265] Photopolymerization initiator (D-2): Omnirad 907 (manufactured by IGM Resins BV)
[0266] Antioxidant (E-1): Sumilizer-GP (Phosphorus / phenol complex type, antioxidant, manufactured by Sumitomo Chemical Co.)
[0267] Antioxidant (E-2): AO-60 (Phenol-based antioxidant, manufactured by ADEKA)
[0268] Leveling agent (F-1): SH8400 (silicone-based leveling agent, manufactured by Dore Dow)
[0269] Leveling agent (F-2): F-554 (Fluorine-based leveling agent, manufactured by DIC)
[0270] Solvent (G-1): PGMEA (propylene glycol monomethyl ether acetate)
[0271] Solvent (G-2): Cyclohexyl acetate
[0272] [Table 3]
[0273]
Claims
Claim 1 A curable resin composition comprising a quantum dot (A), a resin (B), a photopolymerizable compound (C), a photopolymerization initiator (D), an antioxidant (E), a leveling agent (F), and a solvent (G), wherein the photopolymerization initiator (D) comprises an oxime compound, the mass ratio of the resin (B) to the photopolymerizable compound (C) is 2 or more, the resin (B) has a weight-average molecular weight in polystyrene equivalent of 7600 or less, and an acid value of 90 mgKOH / g or more and 150 mgKOH / g or less. Claim 2 A curable resin composition according to claim 1, wherein the resin (B) comprises a resin having an acrylic equivalent of 300 g / eq or more and 2,000 g / eq or less. Claim 3 delete Claim 4 delete Claim 5 In claim 1, the curable resin composition comprises an antioxidant (E) comprising a phosphorus / phenol complex type antioxidant. Claim 6 A curable resin composition according to claim 1, wherein the leveling agent (F) comprises a fluorine-based surfactant or a silicone-based surfactant. Claim 7 A curable resin composition according to claim 1, wherein neither the aliphatic tertiary amine compound nor the aliphatic quaternary ammonium salt compound is included, or at least one of the aliphatic tertiary amine compound and the aliphatic quaternary ammonium salt compound is included in an amount of less than 0.4 mass% with respect to the total amount of solids of the curable resin composition. Claim 8 A cured film formed from a curable resin composition described in any one of claims 1, 2, and 5 to 7. Claim 9 A display device comprising a hardened film as described in claim 8. Claim 10 A method for manufacturing a curable resin composition as described in claim 1, comprising a process for preparing the resin (B), wherein the resin (B) does not contain either an aliphatic tertiary amine compound or an aliphatic quaternary ammonium salt compound, or contains at least one of the aliphatic tertiary amine compound and an aliphatic quaternary ammonium salt compound in an amount of less than 0.8 mass% relative to the total amount of solids of the resin (B). Claim 11 A method of manufacturing according to claim 10, wherein an amine compound is not used as a reaction catalyst in the process of preparing the resin (B).
Citation Information
Patent Citations
Tip cap assembly for closing the injection system
JP2016537064A
Curable composition
WO2016035602A1
Curable composition
WO2016035603A1
Self emission type photosensitive resin composition, color filter manufactured using thereof and image display device having the same
KR1020180056860A
